Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
236.63
+0.04 (0.02%)
Sep 25, 2026, 10:13 AM EDT - Market open
Quest Diagnostics Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Quest Diagnostics stock has a consensus rating of "Buy" and an average price target of $247.73. The average 1-year stock price forecast is 4.69% higher than the current stock price, while the lowest is $204 (-13.79%) and the highest is $265 (+11.99%).
Price Target: $247.73 (+4.69%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 9 | 8 | 7 | 7 | 7 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $250 | Buy | Maintains | $250 | +5.65% | Sep 23, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $250 → $260 | Hold | Reiterates | $250 → $260 | +9.88% | Sep 21, 2026 |
| UBS | UBS | Hold Maintains $232 → $245 | Hold | Maintains | $232 → $245 | +3.54% | Sep 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $260 | Buy | Maintains | $260 | +9.88% | Aug 19, 2026 |
| Argus Research | Argus Research | Buy Maintains $260 | Buy | Maintains | $260 | +9.88% | Jul 29, 2026 |
Financial Forecast
Revenue This Year
12.01B
from 11.04B
Increased by 8.81%
Revenue Next Year
12.57B
from 12.01B
Increased by 4.70%
EPS This Year
11.19
from 9.85
Increased by 13.62%
EPS Next Year
12.06
from 11.19
Increased by 7.78%
EPS and Forward PE are based on non-GAAP adjusted numbers.